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Abstract - In Glioblastoma Multiforme (GBM) image-
derived features (“radiomics”) could help in individualiz-
ing patient management. Simple geometric features of
tumors (necrosis, edema, active tumor) and first-order
statistics inMagnetic Resonance Imaging (MRI) are used
in clinical practice. However, these features provide lim-
ited characterization power because they do not incor-
porate spatial information and thus cannot differentiate
patterns. The aim of this work is to develop and eval-
uate a methodological framework dedicated to building
a prognostic model based on heterogeneity textural fea-
tures of multimodal MRI sequences (T1, T1-contrast, T2
and FLAIR) in GBM. The proposed workflow consists
in i) registering the available 3D multimodal MR images
and segmenting the tumor volume, ii) extracting image
features such as heterogeneity metrics and iii) building
a prognostic model by selecting, ranking and combining
optimal features through machine learning (Support Vec-
tor Machine). This framework was applied to 40 histolog-
ically proven GBM patients with the endpoint being over-
all survival (OS) classified as above or below the median
survival (15 months). The models combining features
from a maximum of two modalities were evaluated us-
ing leave-one-out cross-validation (LOOCV). A classifi-
cation accuracy of 90% (sensitivity 85%, specificity 95%)
was obtained by combining features from T1 pre-contrast
and T1 post-contrast sequences. Our results suggest that
several textural features in each MR sequence have prog-
nostic value in GBM.
Index Terms - Image Processing, Magnetic Resonance
Imaging.
I. INTRODUCTION
Glioblastoma multiforme (GBM) is the most malignant
grade IV primary intracranial tumor of adults according to
the World Health Organization’ histological grading sys-
tem [1]. The prognosis is poor with a median survival of
15 months and occurrence rate is two or three cases per
100,000 per year [2, 3]. The current standard treatment
of GBM is a surgical resection followed by radiotherapy
and chemotherapy [4]. Within this context, multimodal
Magnetic Resonance Imaging (MRI) sequences (T1, T1-
contrast, T2, FLAIR...) play a major role for diagnosis,
treatment planning, as well as prognosis, on which depend
a number of clinical decisions. Thus, image-derived fea-
tures extracted from standard MRI sequences could poten-
tially be combined into a powerful prognostic tool with im-
pact on patient management through higher stratification.
Although novel contrast agents, tracers and imaging se-
quences are being developed to investigate various aspects
of tumor underlying pathophysiological processes, it is rec-
ognized that standard medical images may contain useful
yet still unexploited information that could be useful in a
clinical setting. Image-derived features (also called “ra-
diomics”) extracted from medical images may not only al-
low to be associated with prognosis but also non-invasively
probe molecular and histological profiles of tumors, as a
further step towards personalized medicine. Hence, con-
siderable efforts have been carried out in identifying ra-
diomics as a prognostic factor in GBM. Gutman et al.
conducted an assessment of GBM tumor size and com-
position by using 24 visual observations familiar to neu-
roradiologists from MR sequences dubbed as VASARI,
and found that contrast-enhanced tumor volume and ma-
jor axis length of tumor were strongly associated with poor
survival [5]. Recently, Gevaert et al. evaluated 153 2D
MR image-derived features for the development of a ra-
diogenomic map, establishing a link between image fea-
tures and underlying molecular data. Three features were
found to be correlated with survival, 77 with VASARI, and
7 with molecular subgroups [6]. Mazurowski et al. inves-
tigated 8 MRI derived features and concluded that propor-
tion enhancing tumor and major axis length were prognos-
tic factors [7]. Clinical features such as Karnofsky Perfor-
mance Status (KPS), age, extent of resection and degree
of necrosis were found to be significant prognostic factors
[8]. However, most studies were focused on the geometry
of tumors, which do not incorporate the within-tumor het-
erogeneity characteristics imaged through multimodal MR
sequences. Therefore, quantifying heterogeneity could be
of interest for prognosis in GBM and it can be achieved
Figure 1: The proposed workflow for GBM prognostic model development and validation.
through textural features analysis, which has been found to
be of interest in various pattern recognition applications in
medical imaging [9]. For example textural features have
been used to quantify FDG tracer uptake heterogeneity in
PET images of tumors [10, 11]. Likewise, Zacharaki et al.
used Gabor textural features and geometry from brain tu-
mor as quantitative approach to characterize brain tumor
type and grade from MRI [12].
The aim of this work 1 is to develop and evaluate the prog-
nostic value of textural features quantifying the hetero-
geneity of GBM tumors in baseline multimodal MRI se-
quences. We developed a fully operational workflow for
multimodal MR images pre-processing, registration, seg-
mentation of tumors, characterization of tumors hetero-
geneity, and prognostic model training and validation using
support vector machine (SVM) based on recursive feature
elimination algorithm for feature selection and classifica-
tion [13] (Figure 1). We present preliminary results ob-
tained on 40 patients with leave-one-out cross-validation
(LOOCV).
II. MATERIALS AND METHODS
II.1. Patients population and imaging data
In order to simplify the analysis, patients were divided
into two groups for the classification task: short and long
overall survival (SOS and LOS) with a threshold of 14:8
months corresponding to the median survival (n=20 in each
group) with the standard treatment [4]. The MR images of
GBM for this study were acquired from the Cancer Imag-
ing Archive 2, an imaging portal consisting of images from
four centers (Henry Ford Hospital, University of California
San Francisco, M.D. Anderson Cancer Center, and Emory
University). The MR images are anonymized and publicly
available. Forty patients with histopathologically diag-
nosed GBM and treated with radiotherapy and chemother-
apy were retrospectively analyzed. Mean age of patients
was 59y (median 60y, range 31-80y). There were 25males
and 15 females with median survival of 14:8months (mean
1Conflict of interest: none.
2www.cancerimagingarchive.net
15:5, range 2:8-51:2). All baseline MRI sequences consist
of: 1) T1-weighted pre contrast, 2) T1-weighted post con-
trast, 3) T2-weighted, and 4) FLAIR available for all 40
patients.
II.2. Pre-processing of MRI sequences
MRI sequences were acquired using various acquisition pa-
rameters and pulse sequences thereby with potential impact
on the resulting quantification within the images. Stan-
dardization for comparison was performed using several
sequentially implemented pre-processing steps.
II.2.1. Inhomogeneity correction
The undesirable signal that corrupts the MR images due
to magnetic settings, patients’ position and other factors
is known as inhomogeneity or field bias. These inhomo-
geneities in a same tissue type degrade the performance of
segmentation and classification, based on the assumption
of spatial invariance. Therefore all the images included
in this study were corrected for inhomogeneity using the
N3ITK filter [14].
II.2.2. Mono-modal co-registration
All the MRI sequences (T1 pre-contrast, T2 and FLAIR)
were registered to the T1 post-contrast image using mutual
information similarity metric [15].
II.2.3. Tumor delineation
Prior to segmentation, a fully-automatic and customized
skull-stripping algorithm was used to isolate the brain re-
gion from the MRI sequences [16]. Segmentation of the tu-
mor regions was carried-out using all four MRI sequences
and a single mask with labels representing edema, necrosis
and active tumor was automatically produced. The seg-
mentation algorithm is based on Support Vector Machine
exploiting multimodal voxels’ intensities with subsequent
hierarchical regularization by Conditional Random Fields
[17]. An expert clinician in neuro-oncology (P-J Le Reste)
validated and manually edited the resulting masks when
needed.
II.2.4. Intensity standardization within delineated le-
sions
As a consequence of using different MRI sequences with
the varying intensity ranges, the quantization step which
yields finite range of intensities among modalities and
across patients was employed using equation 1.
V (x) = B
I (x) min ii2

max ii2
  min ii2
 + 1 (1)
where B is the quantization bins value, usually considered
within the range 4-256. We considered 4 different values
in the present work for B: 16, 32, 64, and 128. I is the
intensity of a voxel in the original image and 
 is the set
of voxels in the delineated volume. This quantization step
reduces the spatial variability of intensities (noise) and is
also necessary to compute relevant values for textural fea-
tures and facilitate their comparison. All the above pre-
processing steps except the quantization were carried out
using Brain Tumor Image Analysis software (BraTumIA)3,
a fully dedicated open source software for GBM segmen-
tation using MRI sequences [14, 15, 16, 17].
II.3. Textural features extraction
Thirty-four textural features (Table 1) were extracted based
on the first-order, second-order and higher-order statistics
accounting for intensity distribution in global, local and
regional scale respectively, of each delineated tumor vol-
ume in each of the four MRI sequences. Global scale
textural features were computed from intensity histogram,
local scale textural features were computed from Grey-
level co-occurrence matrix (GLCM) [18], whereas regional
scale textural features were computed from grey-level run-
length (GLRLM) [19] and grey-level size-zone matrices
(GLSZM) [20]. These texture matrices were calculated
in 3D taking into account all 13 directions [21, 22]. All
these features have been somewhat useful in various pat-
tern recognition applications including medical imaging
and were therefore considered in the present work.
II.4. Features selection and ranking
Support Vector Machine Recursive Feature Elimination
(SVM-RFE) algorithm initially proposed by Guyon et al.
for gene selection in a cancer classification problem was
employed for the ranking of features [13]. This method se-
lects the features in a linear separation case, based on the
vector of weighted magnitude jjw jj2 defined as
w =
X
i2
yiixi (2)
where  is the number of training sets,  the total num-
ber of features, y is the class label, x is a feature and 
3Nicole et el. Multimodal glioblastoma segmentation. Software avail-
able at http://istb-software.unibe.ch/bratumia/requirement.php.
Order
of tex-
tural
feature
Scale Description Features
First Global Intensityhistogram
Standard deviation
Skewness
Sum
Mean
Median
Variance
Kurtosis
Second Local
Grey-level
co-occurrence
matrices
(GLCM)
Inertia
Energy
Entropy
Cluster shade
Cluster prominence
Inverse difference moment
Higher Regional
Grey-level
run length
matrix
(GLRLM)
Short run emphasis
Long run emphasis
grey-level non-uniformity
Run length non-uniformity
High grey-level run emp.
Low grey-level run emp.
Short run high grey-level emp.
Long run low grey-level emp.
Short run low grey-level emp.
Long run high grey-level emp.
grey-level
size zone
matrix
(GLSZM)
Short zone emphasis
Large zone emphasis
grey-level non-uniform sp.
hom.
Size zone non-uniformity
Zone percentage
Low grey-level zone emp.
High grey-level zone emp.
Short zone low grey-level emp.
Short zone high grey-level emp
Large zone low grey-level emp.
Large zone high grey-level
emp.
Table 1: 34 textural features were computed ; 6 local scale,
21 regional scale, 7 global scale quantifying textural prop-
erties of delineated tumor volumes.
is the corresponding solution of the SVM classifier. The
features corresponding to smallest weight magnitudes are
recursively eliminated. The whole procedure follows the
nested k-fold cross-validation in training set in order to
correct for the selection bias. The features most frequently
occurring on a given particular rank are assigned said rank-
ing.
II.5. Classification for prognosis
We used multivariate pattern analysis methods “Support
Vector Machine (SVM)4” to solve the classification prob-
lem, as this approach has been intensively studied and
benchmarked against a variety of other techniques [13]. As
a preliminary step in our research, we chose to simplify
the problem by considering a binary classification prob-
lem, in which the two classes are ’long overall survival’
(above the median OS of 14.8 months) and ’short overall
4Chang C-C, Lin C-J. LIBSVM: a library for support vector machines,
2011. Software available at http://www.csie.ntu.edu.tw/ cjlin/libsvm/
Figure 2: Model accuracy, specificity and sensitivity assessed by LOOCV. Left: using 1 modality only, right: all combinations
of 2 modalities.
survival’ (below or equal to 14.8 months). The concate-
nation of multi textural features from each MRI sequence
was fed as input to the algorithm. Four different mod-
els, one for each modality, and six different models cor-
responding to all combinations of a maximum of 2 differ-
ent MRI sequences were trained, tuned and cross-validated
using LOOCV on the 40 patient datasets. Model param-
eters selection for the SVM classifier with a linear ker-
nel was performed using grid-based cross-validation on the
training data. The desired number of features to build the
model were collected in a forward selection manner based
on higher cross-validation accuracy in the training set from
outcome of feature selection and ranking procedure of Sec-
tion II.4.
III. RESULTS
Figure 2 presents the results for ten different models (one
for each MRI sequence, as well as the combination of
all the two MRI sequences) that were trained and vali-
dated using LOOCV. The best results were consistently
obtained in all modalities using textural features calcu-
lated with quantization value of B=64, so only these re-
sults are provided. The best classification results consider-
ing only one MRI sequence at a time were obtained using
a combination of five features (cluster shade, high grey-
level zone emphasis, large zone high grey-level empha-
sis, grey-level non-uniform spectral homogeneity and size
zone non-uniformity) extracted from the T1 post-contrast
sequence, with an accuracy of 82.5%. Models based on
T1 pre-contrast, T2 and FLAIR sequence exploited cluster
prominence, large zone emphasis, cluster shade and grey-
level non-uniformity features, with slightly lower associ-
ated accuracy of 62.5%, 72.5% and 75% respectively. Re-
garding the combination of two different MRI sequences,
the highest accuracy was obtained by combining the T1
pre-contrast and T1 post-contrast sequences, with an as-
sociated accuracy of 90% (sensitivity 85% and specificity
95%). Two features only (high grey-level zone empha-
sis and variance) from T1 pre-contrast and four features
(cluster prominence, short run high grey-level emphasis,
size zone non-uniformity and sum) from T1 post-contrast
contributed in this model. Note that for this best model,
features from first, second and third orders were retained.
The feature subset selection method showed that four fea-
tures from local and regional scales (cluster prominence,
cluster shade, grey-level non-uniformity and size zone
non-uniformity) were consistently considered as relevant.
Overall, the T1 post-contrast MRI sequence seemed to of-
fer the most relevant information regarding prognosis. In
another set of experiments, we built a model with the con-
textual clinical variables such as age, gender, karnofsky
and treatment modality (radiotherapy, chemotherapy and
surgery). The variables gender and treatment modality
were categorized using 1-of-k coding scheme. The model
built using contextual clinical variables only reached a lim-
ited accuracy of 58%. In the multivariate selection when
included with image-derived features, none of these clini-
cal variables were retained for building the model.
IV. DISCUSSION-CONCLUSION
Our results suggest that using multivariate methods such
as SVM with the combination of global, local and regional
textural features quantifying heterogeneity in all four MR
modalities available in routine clinical acquisitions can
provide a model with high prognostic value. However,
one drawback of multivariate methods using high dimen-
sional features is the lack of a framework for estimating the
statical interpretation because unlike univariate methods,
SVM model does not compute statistical tests (and corre-
sponding p-values) associated with the significance level.
Rather, evaluating the SVM models’ maximum weight co-
efficients recursively helps in ranking the significant fea-
Figure 3: Kaplan-Meier survival curves for patients according to left: classification using the median survival and right:
classification obtained by the model. Misclassified patients are indicated by black circles.
tures. In addition, selecting an optimal number of signifi-
cant features and building the SVM models based on for-
ward selection of features gives the highest cross-validation
accuracy. We emphasize that these results are only pre-
liminary and the present work has a few limitations: i)
the analysis included only 40 patients and validation was
carried out using LOOCV, which is more optimistic than
validation in an independent dataset; ii) prognosis analysis
was simplified by considering a binary classification prob-
lem (SOS and LOS) instead of a continuous variable; iii)
we did not investigate the combination of more than two
MR sequences among the four available due to the lim-
ited number of patients. We emphasize however that the
analysis is currently ongoing, and that additional patients
will be included in the future, which will allow for a more
rigorous evaluation of the accuracy, by testing the trained
models on an additional group of patients not used in the
model training. In addition, we expect that by projecting
these image features in a higher dimension using a “kernel
trick” (for eg. Radial Basis Kernel) for non-linear multi-
variate analysis and by combining features from all four
MRI sequences, an even more robust and accurate model
for feature selection and classification can be developed.
However, for a reliable analysis, we will have to wait for
more patients datasets to be processed through the entire
described workflow (pre-processing and segmentation of
the images constitutes the bottleneck for producing more
results). Future work will consist in i) adding more pa-
tients for validation using training and testing groups, ii)
improving the pre-processing steps of voxels spatial resam-
pling, standardization and quantization, as recently sug-
gested [23], as well as updating the bias correction using
N4ITK instead of N3ITK, iii) considering additional fea-
tures to improve the proposed model, iv) building a fully
multimodal MRI model by combining features from more
than two sequences, v) considering survival as a continuous
variable using survival SVM method [24] and vi) building
and comparing models with various other machine learning
based classifier techniques such as random forest or artifi-
cial neural network.
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